Erythropoetin Neuroprotection for Neonatal Cardiac Surgery

NCT00513240 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease
Hypoplastic Left Heart Syndrome
Transposition of the Great Arteries
Aortic Arch Hypoplasia or Interruption

Interventions

DRUG: Erythropoetin
DRUG: Normal saline

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]